the original fmcg company deal, page-6

Hi abdm,
2 sections out of the AGM presentation which I find particularly interesting :


It is very pleasing that OBJ has achieved a significant breakthrough during the year signing a LOI with a major FMCG company that has identified SEVERAL of its product formulations that maybe suited for delivery via OBJ's technologies.


We now know that the original FMCG LOI incorporates several formulations which is very encouraging.
From the wording of this paragraph one can conclude that this partnerhip is of particular interst to OBJ management.
It is the FMCG we expect news from shortly after their consumer acceptance testing for one major drug delivery.


This process can often be measured in years and the timelines are very much controlled by the partnering company. In order that this process can be better streamlined, OBJ has taken the decision to undertake some of the preliminary testing ( in vitro and in vivo ) internally and provide the results to the targeted companies with which OBJ intends partnering.


In vivo testing is cost extensive and such a decision can only mean that we are financed to do so.
This also shows that results are to be expected increasingly fast and updates will be published within shorter periods.